CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $588,195
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-12 | Gelbfish Gary A. Director | Exercise or conversion | +1,000,000 | $1.05 | $1.1M | 3,101,121 |
| 2018-10-12 | Gelbfish Gary A. Director | Shares withheld for taxes | −468,750 | $2.24 | $1.1M | 2,632,371 |
| 2018-10-12 | Gelbfish Gary A. Director | Exercise or conversion · Series B Common Stock Warrant | −1,000,000 | 0 | ||
| 2018-10-01 | Lefkowitz Steven W Director | Grant or award | +10,000 | 221,379 | ||
| 2018-10-01 | Kaplan Myron Director | Grant or award | +10,000 | 316,166 | ||
| 2018-10-01 | Kaplan Myron Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-10-01 | Lefkowitz Steven W Director | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2018-09-10 | Gelbfish Gary A. Director | Other disposition · Series A Common Stock Warrant | −1,000,000 | 0 | ||
| 2018-09-10 | Gelbfish Gary A. Director | Other disposition · Series A Common Stock Warrant | −1,000,000 | 0 | ||
| 2018-08-14 | Dillione Janet Director | Grant or award · Phantom Stock | +13,636 | $0.55 | $7K | 13,636 |
| 2018-05-15 | Dillione Janet Director | Grant or award · Phantom Stock | +37,500 | $0.20 | $8K | 37,500 |
| 2018-03-19 | Masson Elizabeth EVP, Head of Clinical Ops. | Grant or award · Stock Option (Right to Buy Common Stock) | +310,000 | 310,000 | ||
| 2018-02-21 | Kaplan Myron Director | Exercise or conversion | +10,000 | 294,166 | ||
| 2018-02-21 | Kaplan Myron Director | Exercise or conversion · Restricted Stock Units | −10,000 | 0 | ||
| 2018-02-21 | Dillione Janet Director | Exercise or conversion | +15,357 | 107,409 | ||
| 2018-02-21 | Dillione Janet Director | Exercise or conversion · Restricted Stock Units | −15,357 | 0 | ||
| 2018-02-16 | Kaplan Myron Director | Grant or award | +22,000 | 306,166 | ||
| 2018-02-16 | Kaplan Myron Director | Grant or award · Stock Option (Right to Buy Common STock) | +40,000 | 40,000 | ||
| 2018-02-16 | Gelbfish Gary A. Director | Grant or award | +10,000 | 2,111,121 | ||
| 2018-02-16 | Khan Mehmood Director | Grant or award | +12,500 | 464,583 |
Page 18 of 24 · 463 trades